PAHC
Phibro Animal Health Corporation
Price Chart
Latest Quote
$31.07
-0.78 (-2.45%)
Current Price
| Previous Close | $31.85 |
| Open | $31.75 |
| Day High | $32.05 |
| Day Low | $30.93 |
| Volume | 243,880 |
Stock Information
| Quarterly Dividend / Yield | $0.48 / 1.55% |
| Shares Outstanding | 21.07M |
| Quarterly Dividend Yield | 1.55% |
| Quarterly Dividend | $0.48 |
| Total Debt | $788.68M |
| Cash Equivalents | $78.14M |
| Revenue | $1.50B |
| Net Income | $95.23M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.26B |
| P/E Ratio | 13.33 |
| EPS (TTM) | $2.33 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.97B |
| Sales | $1.50B |
| Income | $95.23M |
| Book/sh | $8.92 |
| Cash/sh | $3.71 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.06 |
| Current Ratio | 3.17 |
| Debt/Eq | 217.97 |
| EPS Growth TTM | 15.10% |
Returns & Margins
| ROA | 8.40% |
| ROE | 30.34% |
| Gross Margin | 32.57% |
| Operating Margin | 12.56% |
| Profit Margin | 6.35% |
Ownership
| Insider Ownership | 0.85% |
| Institutional Ownership | 99.90% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 9.29 |
| PEG | 1.68 |
| P/S | 0.84 |
| P/B | 3.48 |
Analyst Data
| Recommendation | hold |
| Target Price | $45.60 |
Technical Indicators
| SMA20 | $31.67 |
| SMA50 | $41.64 |
| SMA200 | $43.14 |
| RSI | 54.75 |
| ATR | 1.5952 |
| Shares Float | 20.87M |
| Short Float | 6.22% |
| Short Ratio | 2.33 |
| Volatility | 0.46 |
| Rel Volume | 0.74 |
Performance History
| Week | -1.46% |
| Month | -7.72% |
| Quarter | -38.53% |
| 6 Months | -22.97% |
| YTD | -16.16% |
| Year | +31.31% |
| 3 Years | +143.97% |
| 5 Years | +20.01% |
| 10 Years | +87.28% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $31.07 | 250,100 |
| 2026-06-18 | $31.85 | 439,600 |
| 2026-06-17 | $30.84 | 238,100 |
| 2026-06-16 | $31.87 | 200,500 |
| 2026-06-15 | $32.28 | 230,900 |
| 2026-06-12 | $31.53 | 183,000 |
| 2026-06-11 | $31.26 | 262,700 |
| 2026-06-10 | $31.18 | 356,300 |
| 2026-06-09 | $32.65 | 208,000 |
| 2026-06-08 | $31.76 | 267,700 |
| 2026-06-05 | $32.43 | 271,500 |
| 2026-06-04 | $33.04 | 704,500 |
| 2026-06-03 | $31.79 | 635,700 |
| 2026-06-02 | $28.40 | 356,600 |
| 2026-06-01 | $29.74 | 478,300 |
| 2026-05-29 | $30.66 | 339,100 |
| 2026-05-28 | $31.70 | 395,800 |
| 2026-05-27 | $32.75 | 390,400 |
| 2026-05-26 | $33.54 | 322,300 |
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
đ° Latest News
PAHC vs. SYK: Which Stock Is the Better Value Option?
Zacks âĸ 2026-06-22T15:40:02Z
What Makes Phibro (PAHC) a New Buy Stock
Zacks âĸ 2026-06-17T16:00:05Z
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
Motley Fool âĸ 2026-06-13T16:40:34Z
PAHC Stock: What's Driving Phibro's Animal Health Growth
Zacks âĸ 2026-06-12T12:27:00Z
3 Value Stocks with Questionable Fundamentals
StockStory âĸ 2026-06-11T13:05:37Z
Is PAHC Undervalued at 10x Earnings vs Peers?
Zacks âĸ 2026-06-11T12:53:00Z
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Zacks âĸ 2026-06-10T13:40:04Z
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair Value
Simply Wall St. âĸ 2026-06-06T18:07:36Z
1 Growth Stock with All-Star Potential and 2 We Question
StockStory âĸ 2026-06-05T19:12:14Z
Why Phibro Animal Health (PAHC) Stock Is Trading Up Today
StockStory âĸ 2026-06-04T00:23:33Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $896,273,000 | $704,587,000 | $679,652,000 | $656,861,000 |
| Cost Of Revenue | $896,273,000 | $704,587,000 | $679,652,000 | $656,861,000 |
| Total Revenue | $1,296,215,000 | $1,017,679,000 | $977,889,000 | $942,261,000 |
| Operating Revenue | $1,296,215,000 | $1,017,679,000 | $977,889,000 | $942,261,000 |
| Expenses | ||||
| Interest Expense | $33,249,000 | $21,970,000 | $17,949,000 | $12,101,000 |
| Total Expenses | $1,185,750,000 | $964,364,000 | $906,042,000 | $863,275,000 |
| Other Income Expense | $-7,870,000 | $-23,863,000 | $-2,455,000 | $5,216,000 |
| Net Non Operating Interest Income Expense | $-34,602,000 | $-18,536,000 | $-15,321,000 | $-11,875,000 |
| Total Other Finance Cost | $3,975,000 | $1,040,000 | $727,000 | $590,000 |
| Interest Expense Non Operating | $33,249,000 | $21,970,000 | $17,949,000 | $12,101,000 |
| Operating Expense | $289,477,000 | $259,777,000 | $226,390,000 | $206,414,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $48,264,000 | $2,416,000 | $32,606,000 | $49,175,000 |
| Net Interest Income | $-34,602,000 | $-18,536,000 | $-15,321,000 | $-11,875,000 |
| Interest Income | $2,622,000 | $4,474,000 | $3,355,000 | $816,000 |
| Normalized Income | $53,851,700 | $21,267,770 | $34,086,365 | $45,628,120 |
| Net Income From Continuing And Discontinued Operation | $48,264,000 | $2,416,000 | $32,606,000 | $49,175,000 |
| Total Operating Income As Reported | $110,465,000 | $53,315,000 | $71,847,000 | $78,986,000 |
| Net Income Common Stockholders | $48,264,000 | $2,416,000 | $32,606,000 | $49,175,000 |
| Net Income | $48,264,000 | $2,416,000 | $32,606,000 | $49,175,000 |
| Net Income Including Noncontrolling Interests | $48,264,000 | $2,416,000 | $32,606,000 | $49,175,000 |
| Net Income Continuous Operations | $48,264,000 | $2,416,000 | $32,606,000 | $49,175,000 |
| Pretax Income | $67,993,000 | $10,916,000 | $54,071,000 | $72,327,000 |
| Interest Income Non Operating | $2,622,000 | $4,474,000 | $3,355,000 | $816,000 |
| Operating Income | $110,465,000 | $53,315,000 | $71,847,000 | $78,986,000 |
| Gross Profit | $399,942,000 | $313,092,000 | $298,237,000 | $285,400,000 |
| Per Share | ||||
| Diluted EPS | $1.19 | $0.06 | $0.81 | $1.21 |
| Basic EPS | $1.19 | $0.06 | $0.81 | $1.21 |
| Other | ||||
| Tax Effect Of Unusual Items | $-2,282,300 | $-5,011,230 | $-974,635 | $1,669,120 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $154,717,000 | $92,927,000 | $108,487,000 | $111,917,000 |
| Total Unusual Items | $-7,870,000 | $-23,863,000 | $-2,455,000 | $5,216,000 |
| Total Unusual Items Excluding Goodwill | $-7,870,000 | $-23,863,000 | $-2,455,000 | $5,216,000 |
| Reconciled Depreciation | $45,605,000 | $36,178,000 | $34,012,000 | $32,705,000 |
| EBITDA (Bullshit earnings) | $146,847,000 | $69,064,000 | $106,032,000 | $117,133,000 |
| EBIT | $101,242,000 | $32,886,000 | $72,020,000 | $84,428,000 |
| Diluted Average Shares | $40,700,000 | $40,523,000 | $40,504,000 | $40,500,000 |
| Basic Average Shares | $40,500,000 | $40,504,000 | $40,504,000 | $40,500,000 |
| Diluted NI Availto Com Stockholders | $48,264,000 | $2,416,000 | $32,606,000 | $49,175,000 |
| Tax Provision | $19,729,000 | $8,500,000 | $21,465,000 | $23,152,000 |
| Gain On Sale Of Security | $-7,870,000 | $-23,863,000 | $-2,455,000 | $5,216,000 |
| Selling General And Administration | $289,477,000 | $259,777,000 | $226,390,000 | $206,414,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $189,568,000 | $157,051,000 | $174,248,000 | $145,355,000 |
| Total Assets | $1,360,900,000 | $982,184,000 | $971,397,000 | $931,699,000 |
| Total Non Current Assets | $550,294,000 | $381,187,000 | $385,674,000 | $365,467,000 |
| Other Non Current Assets | $20,215,000 | $8,188,000 | $9,439,000 | $10,134,000 |
| Non Current Prepaid Assets | $610,000 | $1,646,000 | $6,617,000 | $5,905,000 |
| Non Current Deferred Assets | $25,548,000 | $19,371,000 | $8,711,000 | $5,849,000 |
| Non Current Deferred Taxes Assets | $25,548,000 | $19,371,000 | $8,711,000 | $5,849,000 |
| Financial Assets | $89,000 | $0 | $10,225,000 | $12,976,000 |
| Goodwill And Other Intangible Assets | $96,114,000 | $99,590,000 | $108,261,000 | $117,087,000 |
| Other Intangible Assets | $36,469,000 | $45,033,000 | $54,987,000 | $63,861,000 |
| Current Assets | $810,606,000 | $600,997,000 | $585,723,000 | $566,232,000 |
| Other Current Assets | $61,159,000 | $51,021,000 | $63,393,000 | $49,289,000 |
| Inventory | $444,425,000 | $265,911,000 | $277,570,000 | $259,158,000 |
| Receivables | $227,983,000 | $169,452,000 | $163,479,000 | $166,537,000 |
| Accounts Receivable | $227,983,000 | $169,452,000 | $163,479,000 | $166,537,000 |
| Allowance For Doubtful Accounts Receivable | $-2,257,000 | $-1,461,000 | $-1,590,000 | $-3,510,000 |
| Gross Accounts Receivable | $230,240,000 | $170,913,000 | $165,069,000 | $170,047,000 |
| Cash Cash Equivalents And Short Term Investments | $77,039,000 | $114,613,000 | $81,281,000 | $91,248,000 |
| Cash And Cash Equivalents | $68,039,000 | $70,613,000 | $41,281,000 | $74,248,000 |
| Debt | ||||
| Net Debt | $650,646,000 | $417,471,000 | $433,555,000 | $358,677,000 |
| Total Debt | $761,552,000 | $525,459,000 | $509,966,000 | $470,484,000 |
| Long Term Debt And Capital Lease Obligation | $736,175,000 | $488,204,000 | $481,618,000 | $449,433,000 |
| Long Term Debt | $702,435,000 | $458,289,000 | $452,541,000 | $417,925,000 |
| Current Debt And Capital Lease Obligation | $25,377,000 | $37,255,000 | $28,348,000 | $21,051,000 |
| Current Debt | $16,250,000 | $29,795,000 | $22,295,000 | $15,000,000 |
| Other Current Borrowings | $16,250,000 | $29,795,000 | $22,295,000 | $15,000,000 |
| Liabilities | ||||
| Minimum Pension Liabilities | $-17,027,000 | $-17,489,000 | $-25,696,000 | $-25,855,000 |
| Total Liabilities Net Minority Interest | $1,075,218,000 | $725,543,000 | $688,888,000 | $669,257,000 |
| Total Non Current Liabilities Net Minority Interest | $781,745,000 | $521,395,000 | $512,888,000 | $478,425,000 |
| Other Non Current Liabilities | $11,361,000 | $6,846,000 | $6,076,000 | $5,947,000 |
| Derivative Product Liabilities | $3,885,000 | $0 | - | - |
| Non Current Deferred Liabilities | $19,471,000 | $14,218,000 | $12,146,000 | $9,264,000 |
| Non Current Deferred Taxes Liabilities | $19,471,000 | $14,218,000 | $12,146,000 | $9,264,000 |
| Current Liabilities | $293,473,000 | $204,148,000 | $176,000,000 | $190,832,000 |
| Other Current Liabilities | $31,237,000 | $17,540,000 | $18,859,000 | $18,904,000 |
| Payables And Accrued Expenses | $185,101,000 | $111,741,000 | $99,434,000 | $116,599,000 |
| Payables | $146,598,000 | $88,498,000 | $82,516,000 | $102,807,000 |
| Total Tax Payable | $8,397,000 | $2,931,000 | $8,663,000 | $7,211,000 |
| Accounts Payable | $138,201,000 | $85,567,000 | $73,853,000 | $95,596,000 |
| Equity | ||||
| Common Stock Equity | $285,682,000 | $256,641,000 | $282,509,000 | $262,442,000 |
| Total Equity Gross Minority Interest | $285,682,000 | $256,641,000 | $282,509,000 | $262,442,000 |
| Stockholders Equity | $285,682,000 | $256,641,000 | $282,509,000 | $262,442,000 |
| Gains Losses Not Affecting Retained Earnings | $-124,018,000 | $-123,527,000 | $-114,210,000 | $-121,113,000 |
| Other Equity Adjustments | $-1,705,000 | $9,800,000 | $18,382,000 | $15,610,000 |
| Retained Earnings | $272,701,000 | $243,886,000 | $260,912,000 | $247,748,000 |
| Long Term Equity Investment | $5,142,000 | $5,183,000 | $5,027,000 | $4,362,000 |
| Other | ||||
| Ordinary Shares Number | $40,533,608 | $40,503,608 | $40,503,608 | $40,503,608 |
| Share Issued | $40,533,608 | $40,503,608 | $40,503,608 | $40,503,608 |
| Tangible Book Value | $189,568,000 | $157,051,000 | $174,248,000 | $145,355,000 |
| Invested Capital | $1,004,367,000 | $744,725,000 | $757,345,000 | $695,367,000 |
| Working Capital | $517,133,000 | $396,849,000 | $409,723,000 | $375,400,000 |
| Capital Lease Obligations | $42,867,000 | $37,375,000 | $35,130,000 | $37,559,000 |
| Total Capitalization | $988,117,000 | $714,930,000 | $735,050,000 | $680,367,000 |
| Foreign Currency Translation Adjustments | $-113,452,000 | $-124,004,000 | $-115,062,000 | $-119,034,000 |
| Unrealized Gain Loss | $8,166,000 | $8,166,000 | $8,166,000 | $8,166,000 |
| Additional Paid In Capital | $136,995,000 | $136,278,000 | $135,803,000 | $135,803,000 |
| Capital Stock | $4,000 | $4,000 | $4,000 | $4,000 |
| Common Stock | $4,000 | $4,000 | $4,000 | $4,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Employee Benefits | $10,853,000 | $12,127,000 | $13,048,000 | $13,781,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $10,853,000 | $12,127,000 | $13,048,000 | $13,781,000 |
| Long Term Capital Lease Obligation | $33,740,000 | $29,915,000 | $29,077,000 | $31,508,000 |
| Current Capital Lease Obligation | $9,127,000 | $7,460,000 | $6,053,000 | $6,051,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $51,758,000 | $37,612,000 | $29,359,000 | $34,278,000 |
| Current Accrued Expenses | $38,503,000 | $23,243,000 | $16,918,000 | $13,792,000 |
| Investments And Advances | $11,689,000 | $11,488,000 | $11,094,000 | $10,346,000 |
| Other Investments | $6,547,000 | $6,305,000 | $6,067,000 | $5,984,000 |
| Goodwill | $59,645,000 | $54,557,000 | $53,274,000 | $53,226,000 |
| Net PPE | $396,029,000 | $240,904,000 | $231,327,000 | $203,170,000 |
| Accumulated Depreciation | $-278,960,000 | $-245,354,000 | $-263,626,000 | $-240,965,000 |
| Gross PPE | $674,989,000 | $486,258,000 | $494,953,000 | $444,135,000 |
| Construction In Progress | $32,716,000 | $23,892,000 | $34,743,000 | $30,648,000 |
| Other Properties | $41,339,000 | $37,604,000 | $35,759,000 | $37,680,000 |
| Machinery Furniture Equipment | $391,992,000 | $273,965,000 | $291,454,000 | $274,298,000 |
| Buildings And Improvements | $175,892,000 | $120,173,000 | $105,184,000 | $89,582,000 |
| Land And Improvements | $33,050,000 | $30,624,000 | $27,813,000 | $11,927,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $253,817,000 | $169,562,000 | $170,892,000 | $156,660,000 |
| Work In Process | $27,982,000 | $23,550,000 | $22,350,000 | $15,468,000 |
| Raw Materials | $162,626,000 | $72,799,000 | $84,328,000 | $87,030,000 |
| Other Short Term Investments | $9,000,000 | $44,000,000 | $40,000,000 | $17,000,000 |
| Defined Pension Benefit | - | - | - | $0 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $41,831,000 | $46,356,000 | $-38,484,000 | $-5,395,000 |
| Operating Activities | ||||
| Operating Cash Flow | $80,124,000 | $87,594,000 | $13,310,000 | $31,649,000 |
| Cash Flow From Continuing Operating Activities | $80,124,000 | $87,594,000 | $13,310,000 | $31,649,000 |
| Operating Gains Losses | $600,000 | $23,788,000 | $-10,398,000 | $-6,011,000 |
| Investing Activities | ||||
| Capital Expenditure | $-38,293,000 | $-41,238,000 | $-51,794,000 | $-37,044,000 |
| Investing Cash Flow | $-288,688,000 | $-48,194,000 | $-74,018,000 | $-22,582,000 |
| Cash Flow From Continuing Investing Activities | $-288,688,000 | $-48,194,000 | $-74,018,000 | $-22,582,000 |
| Net Other Investing Changes | $1,134,000 | $326,000 | $776,000 | $620,000 |
| Capital Expenditure Reported | $-38,293,000 | $-41,238,000 | $-51,794,000 | $-37,044,000 |
| Financing Activities | ||||
| Financing Cash Flow | $207,134,000 | $-6,768,000 | $26,987,000 | $16,343,000 |
| Cash Flow From Continuing Financing Activities | $207,134,000 | $-6,768,000 | $26,987,000 | $16,343,000 |
| Net Other Financing Charges | $-9,403,000 | $-31,000 | $3,744,000 | $-4,840,000 |
| Cash Dividends Paid | $-19,449,000 | $-19,442,000 | $-19,442,000 | $-19,442,000 |
| Common Stock Dividend Paid | $-19,449,000 | $-19,442,000 | $-19,442,000 | $-19,442,000 |
| Issuance Of Capital Stock | - | - | - | - |
| Net Common Stock Issuance | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-946,014,000 | $-263,295,000 | $-283,315,000 | $-256,375,000 |
| Issuance Of Debt | $1,182,000,000 | $276,000,000 | $326,000,000 | $297,000,000 |
| Interest Paid Supplemental Data | $32,073,000 | $17,253,000 | $14,575,000 | $11,159,000 |
| Income Tax Paid Supplemental Data | $13,400,000 | $15,430,000 | $20,410,000 | $17,854,000 |
| End Cash Position | $68,039,000 | $70,613,000 | $41,281,000 | $74,248,000 |
| Beginning Cash Position | $70,613,000 | $41,281,000 | $74,248,000 | $50,212,000 |
| Effect Of Exchange Rate Changes | $-1,144,000 | $-3,300,000 | $754,000 | $-1,374,000 |
| Changes In Cash | $-1,430,000 | $32,632,000 | $-33,721,000 | $25,410,000 |
| Net Issuance Payments Of Debt | $235,986,000 | $12,705,000 | $42,685,000 | $40,625,000 |
| Net Long Term Debt Issuance | $235,986,000 | $12,705,000 | $42,685,000 | $40,625,000 |
| Long Term Debt Payments | $-946,014,000 | $-263,295,000 | $-283,315,000 | $-256,375,000 |
| Long Term Debt Issuance | $1,182,000,000 | $276,000,000 | $326,000,000 | $297,000,000 |
| Net Investment Purchase And Sale | $35,000,000 | $-4,000,000 | $-23,000,000 | $27,353,000 |
| Sale Of Investment | $49,000,000 | $61,523,000 | $17,000,000 | $91,453,000 |
| Purchase Of Investment | $-14,000,000 | $-65,523,000 | $-40,000,000 | $-64,100,000 |
| Net Business Purchase And Sale | $-286,529,000 | $-3,282,000 | $0 | $-13,511,000 |
| Purchase Of Business | $-286,529,000 | $-3,282,000 | $0 | $-13,511,000 |
| Change In Working Capital | $-21,562,000 | $33,114,000 | $-41,133,000 | $-44,639,000 |
| Change In Other Current Assets | $-14,774,000 | $14,962,000 | $-6,669,000 | $-3,525,000 |
| Change In Payables And Accrued Expense | $92,714,000 | $24,189,000 | $-28,577,000 | $29,510,000 |
| Change In Accrued Expense | $47,159,000 | $12,189,000 | $-5,747,000 | $3,152,000 |
| Change In Payable | $45,555,000 | $12,000,000 | $-22,830,000 | $26,358,000 |
| Change In Account Payable | $45,555,000 | $12,000,000 | $-22,830,000 | $26,358,000 |
| Change In Inventory | $-44,294,000 | $2,641,000 | $-11,222,000 | $-46,999,000 |
| Change In Receivables | $-55,208,000 | $-8,678,000 | $5,335,000 | $-23,625,000 |
| Changes In Account Receivables | $-55,208,000 | $-8,678,000 | $5,335,000 | $-23,625,000 |
| Other Non Cash Items | $6,051,000 | $-537,000 | $1,061,000 | $1,225,000 |
| Stock Based Compensation | $717,000 | $475,000 | $0 | $0 |
| Asset Impairment Charge | $5,328,000 | $0 | $0 | - |
| Deferred Tax | $-4,879,000 | $-7,840,000 | $-2,838,000 | $-806,000 |
| Deferred Income Tax | $-4,879,000 | $-7,840,000 | $-2,838,000 | $-806,000 |
| Depreciation Amortization Depletion | $45,605,000 | $36,178,000 | $34,012,000 | $32,705,000 |
| Depreciation And Amortization | $45,605,000 | $36,178,000 | $34,012,000 | $32,705,000 |
| Amortization Cash Flow | $7,843,000 | $9,661,000 | $9,696,000 | $8,924,000 |
| Amortization Of Intangibles | $7,843,000 | $9,661,000 | $9,696,000 | $8,924,000 |
| Depreciation | $37,762,000 | $26,517,000 | $24,316,000 | $23,781,000 |
| Pension And Employee Benefit Expense | $0 | $10,674,000 | $0 | $0 |
| Net Foreign Currency Exchange Gain Loss | $600,000 | $13,114,000 | $-10,398,000 | $-4,808,000 |
| Net Income From Continuing Operations | $48,264,000 | $2,416,000 | $32,606,000 | $49,175,000 |
| Net Short Term Debt Issuance | - | - | - | $50,000,000 |
| Short Term Debt Payments | - | - | - | $-247,000,000 |
| Short Term Debt Issuance | - | - | - | $297,000,000 |
| Gain Loss On Investment Securities | - | - | - | $-1,203,000 |
Fetched: 2026-06-20